This week's View offers key points to remember from a review on heart failure with preserved ejection fraction and diabetes and addresses the comparative durabilities of transcatheter aortic valve replacement (TAVR) and surgical bioprosthetic aortic valve replacement and the incidence of structural valve degeneration 5-10 years after TAVR.

Subscribe on iTunes | Subscribe on Google Play

Keywords: EaglesEyeView, Adiposity, Aortic Valve Stenosis, Bioprosthesis, Aortic Valve Insufficiency, Cardiac Surgical Procedures, Cardio-Renal Syndrome, Constriction, Pathologic, Coronary Stenosis, Diabetes Mellitus, Caloric Restriction, Endocarditis, Comorbidity, Diagnostic Imaging, Echocardiography, Exercise Therapy, Diuretics, Fatty Acids, Glucagon-Like Peptide 1, Heart Valve Prosthesis, Heart Valve Diseases, Hemodynamics, Hospital Mortality, Neprilysin, Heart Failure, Inflammation, Patient Readmission, Obesity, Quality of Health Care, Sodium-Glucose Transport Proteins, Up-Regulation, Secondary Prevention, Transcatheter Aortic Valve Replacement, Stroke Volume

< Back to Listings